Cantor Fitzgerald Maintains Overweight on Tenet Healthcare, Raises Price Target to $104
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has maintained an Overweight rating on Tenet Healthcare (NYSE:THC) and increased the price target from $94 to $104.
February 09, 2024 | 2:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reaffirmed an Overweight rating on Tenet Healthcare and raised the price target to $104.
The upgrade in price target by a reputable analyst like Sarah James suggests a strong confidence in Tenet Healthcare's future performance. This is likely to positively influence investor sentiment and potentially increase the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100